[1] COULL A J，LOVETT J K，ROTHWELL P M.

Population based study of early risk of stroke

after transient ischaemic attack or minor stroke：

Implications for public education and organisation of

services[J]. BMJ，2004，328（7435）：326.

[2] ROTHWELL P M，ELIASZIW M，GUTNIKOV S

A，et al. Endarterectomy for symptomatic carotid

stenosis in relation to clinical subgroups and timing

of surgery[J]. Lancet，2004，363（9413）：915-924.

[3] LAVALLEE P C，MESEGUER E，ABBOUD H，et

al. A transient ischaemic attack clinic with roundthe-

clock access（SOS-TIA）：Feasibility and

effects[J]. Lancet Neurol，2007，6（11）：953-960.

[4] ROTHWELL P M，GILES M F，CHANDRATHEVA

A，et al. Effect of urgent treatment of transient

ischaemic attack and minor stroke on early recurrent

stroke（express study）：A prospective populationbased

sequential comparison[J]. Lancet，2007，370

（9596）：1432-1442.

[5] JOHNSTON S C，GRESS D R，BROWNER W S，et

al. Short-term prognosis after emergency department

diagnosis of TIA[J]. JAMA，2000，284（22）：2901-

2906.

[6] LUENGO F R，GRAY A M，ROTHWELL P M.

Effect of urgent treatment for transient ischaemic

attack and minor stroke on disability and hospital

costs（express study）：A prospective populationbased

sequential comparison[J]. Lancet Neurol，

2009，8（3）：235-243.

[7] MARTINEZ M M，MARTINEZ S P，FUENTES

B，et al. Transient ischaemic attacks clinics provide

equivalent and more efficient care than early inhospital

assessment[J]. Eur J Neurol，2013，20（2）：

338-343.

[8] WARRIOR L，PRABHAKARAN S. Transient

ischemic attack evaluation models：Hospitalization，

same-day clinics，or rapid evaluation units[J]. Am J

Ther，2011，18（1）：45-50.

[9] LAVALLEE P，AMARENCO P. TIA clinic：A major advance in management of transient ischemic

attacks[J/OL]. Front Neurol Neurosci，2014，33：30-

40. https：//doi.org/10.1159/000351890.

[10] AMARENCO P，LABREUCHE J，LAVALLEE

P C. Patients with transient ischemic attack with

ABCD2<4 can have similar 90-day stroke risk

as patients with transient ischemic attack with

ABCD2≥4[J]. Stroke，2012，43（3）：863-865.

[11] EASTON J D，SAVER J L，ALBERS G W，et al.

Definition and evaluation of transient ischemic attack：

a scientific statement for healthcare professionals

from the American Heart Association/American

Stroke Association Stroke Council; Council on

Cardiovascular Surgery and Anesthesia; Council on

Cardiovascular Radiology and Intervention; Council

on Cardiovascular Nursing; and the Interdisciplinary

Council on Peripheral Vascular Disease. The

American Academy of Neurology affirms the

value of this statement as an educational tool for

neurologists[J]. Stroke，2009，40（6）：2276-2293.

[12] TOUZE E，COSTE J，VOICU M，et al.

Importance of in-hospital initiation of therapies

and therapeutic inertia in secondary stroke

prevention：IMplementation of Prevention After a

Cerebrovascular evenT (IMPACT) Study[J]. Stroke，

2008，39（6）：1834-1843.

[13] BODEN A B，STILLMAN J，ROBERTS E T，et al.

Comparison of Acute Stroke Preparedness Strategies

to Decrease Emergency Department Arrival Time

in a Multiethnic Cohort：The Stroke Warning

Information and Faster Treatment Study[J]. Stroke，

2015，46（7）：1806-1812.

[14] ROSS M A，COMPTON S，MEDADO P，et al.

An emergency department diagnostic protocol

for patients with transient ischemic attack：A

randomized controlled trial[J]. Ann Emerg Med，

2007，50（2）：109-119.

[15] KENNEDY J，HILL M D，RYCKBORST K J，et

al. Fast assessment of stroke and transient ischaemic

attack to prevent early recurrence（FASTER）：A

randomised controlled pilot trial[J]. Lancet Neurol，

2007，6（11）：961-969.

[16] WANG Y，WANG Y，ZHAO X，et al. Clopidogrel

with aspirin in acute minor stroke or transient

ischemic attack[J]. N Engl J Med，2013，369（14）：

11-19.

[17] LIN J，ZHENG H，CUCCHIARA B L，et al.

Association of Lp-PLA2-A and early recurrence

of vascular events after TIA and minor stroke[J].

Neurology，2015，85（18）：1585-1591.

[18] JOHNSTON S C，EASTON J D，FARRANT M， et al. Platelet-oriented inhibition in new TIA and

minor ischemic stroke（POINT）trial：rationale and

design[J]. Int J Stroke，2013，8（6）：479-483.

[19] WANG Y，ZHAO X，LIN J，et al. Association

Between CYP2C19 Loss-of-Function Allele Status

and Efficacy of Clopidogrel for Risk Reduction

Among Patients With Minor Stroke or Transient

Ischemic Attack[J]. JAMA，2016，316（1）：70-78.

[20] The Stroke Prevention in Reversible Ischemia

Trial (SPIRIT) Study Group. A randomized trial of

anticoagulants versus aspirin after cerebral ischemia

of presumed arterial origin[J]. Ann Neurol，1997，42

（6）：857-865.

[21] DE SCHRYVER E L. Design of ESPRIT：an

international randomized trial for secondary

prevention after non-disabling cerebral ischaemia

of arterial origin. European/Australian Stroke

Prevention in Reversible Ischaemia Trial（ESPRIT）

group[J]. Cerebrovasc Dis，2000，10（2）：147-150.

[22] DE SCHRYVER E L. European/Australian Stroke

Prevention in Reversible Ischemia Trial Group.

ESPRIT：Protocol change[J]. Cerebrovasc Dis，2001，

11（3）：286.

[23] Warfarin-Aspirin Symptomatic Intracranial Disease

Trial Investigators. Design，progress and challenges

of a double-blind trial of warfarin versus aspirin

for symptomatic intracranial arterial stenosis[J].

Neuroepidemiology，2003，22（2）：106-117.

[24] SANDERCOCK P A，GIBSON L M，LIU M.

Anticoagulants for preventing recurrence following

presumed non-cardioembolic ischaemic stroke

or transient ischaemic attack[J/OL]. Cochrane

Database Syst Rev，2009：CD000248. https：//doi.

org/10.1002/14651858.CD000248.pub2.

[25] BRAVATA D M，WELLS C K，KERNAN W N，et

al. Association between impaired insulin sensitivity

and stroke[J]. Neuroepidemiology，2005，25（2）：

69-74.

[26] HANKEY G J，FENG T Z. Insulin resistance a

possible causal and treatable risk factor for ischemic

stroke[J]. Arch Neurol，2010，67（10）：1177-1178.

[27] RUNDEK T，GARDENER H，XU Q，et al. Insulin

resistance and risk of ischemic stroke among

nondiabetic individuals from the northern Manhattan

study[J]. Arch Neurol，2010，67（10）：1195-1200.

[28] THACKER E L，PSATY B M，MCKNIGHT B，et al. Fasting and post-glucose load measures of

insulin resistance and risk of ischemic stroke in older

adults[J]. Stroke，2011，42（12）：3347-3351.

[29] KERNAN W N，INZUCCHI S E，VISCOLI C

M，et al. Insulin resistance and risk for stroke[J].

Neurology，2002，59（6）：809-815.

[30] BAS D F，OZDEMIR A O，COLAK E，et al. Higher

insulin resistance level is associated with worse

clinical response in acute ischemic stroke patients

treated with intravenous thrombolysis[J]. Transl

Stroke Res，2016，7（3）：167-171.

[31] CALLEJA A I，GARCIA B P，CORTIJO E，et al.

Insulin resistance is associated with a poor response

to intravenous thrombolysis in acute ischemic

stroke[J]. Diabetes Care，2011，34（11）：2413-2417.

[32] YU A Y，HILL M D，COUTTS S B. Should minor

stroke patients be thrombolyzed? A focused review

and future directions[J]. Int J Stroke，2015，10（3）：

292-297.

[33] National Institute of Neurological Disorders Stroke

rt-PA Stroke Study Group. Recombinant tissue

plasminogen activator for minor strokes：The

National Institute of Neurological Disorders and

Stroke rt-PA Stroke Study experience[J]. Ann Emerg

Med，2005，46（3）：243-252.

[34] Khatri P，Tayama D，Cohen G，et al. Effect of

Intravenous Recombinant Tissue-Type Plasminogen

Activator in Patients With Mild Stroke in the Third

International Stroke Trial-3：Post Hoc Analysis[J].

Stroke，2015，46（8）：2325-2327.

[35] ROMANO J G，SMITH E E，LIANG L，et al.

Outcomes in mild acute ischemic stroke treated with

intravenous thrombolysis：A retrospective analysis

of the Get With the Guidelines-Stroke registry[J].

JAMA Neurol，2015，72（4）：423-431.

[36] CHOI J C，JANG M U，KANG K，et al.

Comparative effectiveness of standard care with

IV thrombolysis versus without IV thrombolysis

for mild ischemic stroke[J/OL]. J Am Heart

Assoc，2015，4：e001306. https：//doi.org/10.1161/

JAHA.114.000596.

[37] ZHAO J Z，WANG S，LI J S，et al. The perioperative

use of ceftriaxone as infection prophylaxis in

neurosurgery[J]. Clin Neurol Neurosurg，1995，97（2

Suppl）：285-289.